S. Pol

664 total citations
11 papers, 62 citations indexed

About

S. Pol is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, S. Pol has authored 11 papers receiving a total of 62 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hepatology, 3 papers in Epidemiology and 2 papers in Surgery. Recurrent topics in S. Pol's work include Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (2 papers) and Hepatitis B Virus Studies (2 papers). S. Pol is often cited by papers focused on Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (2 papers) and Hepatitis B Virus Studies (2 papers). S. Pol collaborates with scholars based in France, United States and Netherlands. S. Pol's co-authors include Charles Masson, Éric Bruckert, Thao Pham, Séverine Guillaume, Philippe Goupille, Laure Gossec, Michel De Bandt, Jacques Morel, Thierry Schaeverbeke and Arnaud Constantin and has published in prestigious journals such as Journal of Hepatology, Digestive and Liver Disease and Joint Bone Spine.

In The Last Decade

S. Pol

7 papers receiving 59 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
S. Pol France 4 27 24 23 13 11 11 62
Cécile Wibaux France 4 6 0.2× 18 0.8× 17 0.7× 13 1.0× 3 0.3× 8 71
Veena Zamvar United Kingdom 5 16 0.6× 13 0.5× 14 0.6× 19 1.5× 2 0.2× 8 93
Robert Boulton-Jones United Kingdom 3 28 1.0× 11 0.5× 136 5.9× 12 0.9× 9 0.8× 3 157
Tamar Shwartz Israel 5 11 0.4× 19 0.8× 12 0.5× 22 1.7× 54 4.9× 7 111
Vanessa Rodríguez Puerto Rico 6 3 0.1× 32 1.3× 36 1.6× 16 1.2× 6 0.5× 11 84
Floris F. van den Brand Netherlands 4 65 2.4× 12 0.5× 68 3.0× 6 0.5× 8 0.7× 8 101
Ana Rita Prata Portugal 5 3 0.1× 20 0.8× 11 0.5× 10 0.8× 20 1.8× 13 58
Luz Yadira Bravo‐Gallego Spain 5 7 0.3× 25 1.0× 15 0.7× 8 0.6× 2 0.2× 12 59
Lei Hua United States 4 22 0.8× 8 0.3× 17 0.7× 3 0.2× 2 0.2× 9 52
P. Biscay France 2 10 0.4× 39 1.6× 15 0.7× 22 1.7× 3 58

Countries citing papers authored by S. Pol

Since Specialization
Citations

This map shows the geographic impact of S. Pol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Pol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Pol more than expected).

Fields of papers citing papers by S. Pol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Pol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Pol. The network helps show where S. Pol may publish in the future.

Co-authorship network of co-authors of S. Pol

This figure shows the co-authorship network connecting the top 25 collaborators of S. Pol. A scholar is included among the top collaborators of S. Pol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Pol. S. Pol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
3.
Grebely, Jason, Ira M. Jacobson, Zeid Kayali, et al.. (2017). SOF/VEL/VOX for 8 or 12 weeks is well tolerated and results in high SVR12 rates in patients receiving opioid substitution therapy. Journal of Hepatology. 66(1). S513–S514. 11 indexed citations
4.
Chevaliez, Stéphane, P. Trimoulet, Sylvie Larrat, et al.. (2017). Effect of resistance-associated substitutions on retreatment of direct acting antiviral-exposed patients in the real-world setting (ANRS CO22 HEPATHER). Journal of Hepatology. 66(1). S84–S84. 2 indexed citations
6.
Sultanik, Philippe, Armanda Casrouge, Estelle Mottez, et al.. (2013). 1177 BASELINE Phospho-Stat1 LEVEL IN PBMC IS A NON-INVASIVE BIOMARKER OF EARLY VIROLOGICAL RESPONSE TO TRIPLE THERAPY IN CHRONIC HCV INFECTION – ANRS C10–08 STUDY. Journal of Hepatology. 58. S478–S478.
8.
Sogni, Philippe, H. Fontaine, Vincent Mallet, et al.. (2010). 1023 ADHERENCE TO ANTI-HBV ANALOGUES IN CLINICAL PRACTICE IS ASSOCIATED WITH VIROLOGICAL EFFICACY AND DEPENDS ON THE DURATION OF TREATMENTS AND THE PHYSICIAN'S EXPERIENCE. Journal of Hepatology. 52. S395–S396. 1 indexed citations
9.
Pham, Thao, Arnaud Constantin, Michel De Bandt, et al.. (2010). Tocilizumab: Therapy and safety management. Joint Bone Spine. 77. S3–S100. 35 indexed citations
10.
Cacoub, P., Guillaume Pénaranda, Fabrice Carrat, et al.. (2008). 775 INSULIN RESISTANCE AND RESPONSE TO THERAPY IN HIV-HCV COINFECTED PATIENTS: HOMAVIC-ANRS HC-02 STUDY. Journal of Hepatology. 48. S289–S289.
11.
Lencioni, Riccardo, Clotilde Della Pina, Laura Crocetti, et al.. (2006). Advances in Diagnostic Imaging. DIAL (Catholic University of Leuven). 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026